About this trial
Establish a clinical diagnosis and treatment and long-term follow-up database of preterm infants, and analyze the effects of prenatal factors (including genetic characteristics, maternal diseases, etc.), postnatal diagnosis and treatment measures and family maintenance environment after discharge on preterm infant mortality and major diseases in the near and long term.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Live born newborns with gestational age ≤ 36 + 6 weeks
Transfer to the neonatal ward of Shanghai Children's medical center within 24 hours after birth
Those who have lived in Shanghai for more than 1 year and plan to live in Shanghai for a long time. Parents voluntarily participated in the study and signed informed consent
Disqualifiers
Premature infants: termination of treatment due to family factors (non-disease reasons) and hospitalization time ≤ 2 weeks
Major congenital malformations
Parents refuse to participate in the study
Trial population
premature infants with gestational age ≤ 36 + 6 weeks.
Trial design
Cohort
Prospective
Treatments tested in this trial
Griffiths development scales
Diagnostic testGriffiths development scales Chinese Edition (gds-c) was used to evaluate the development levels of children up to 6 years and WISC for children more than 6 years.
Treatment groups
Trial outcomes
Primary outcomes
neural development at 1 year old
Taking Griffiths development scales Chinese Edition test for all the participants.
neural development at 2 years old
Taking Griffiths development scales Chinese Edition test for partial participants.
neural development at 6 years old
Taking Wechsler Intelligence Scale for participants.
Growth and neural development at 12 years old
Taking Wechsler Intelligence Scale for participants.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.